Hubbard Cristin bought BMRN

March 17, 2025 · Form 4 insider transaction

Hubbard Cristin bought 13,310 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

13,310

Price

$0.00

Total value

N/A

InsiderHubbard Cristin

Role—

CompanyBioMarin Pharmaceutical Inc. (BMRN)

SecurityCommon Stock

Transaction codeA — Grant or award

Transaction dateMarch 17, 2025

Filing dateMarch 18, 2025

Shares owned after32,700

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Restricted stock units granted March 17, 2025. Price not applicable.

View the original Form 4 on SEC EDGAR